Orchid Pharma signs licensing, supply pact with Russia’s Pharmasyntez for Exblifep
Orchid Pharma Ltd on Tuesday (July 7) said it has signed a licensing and supply agreement with Pharmasyntez JSC, Russia, for the commercialisation of Exblifep (cefepime/enmetazobactam) in the Russian market. The agreement is subject to regulatory approval from the Ministry of Health of the Russian Federation. Exblifep is a novel combination antibiotic indicated for the…
